Company Registration No. 14658004 (England and Wales)
Gateshead Pharma Limited
Unaudited accounts
for the year ended 31 March 2025
Gateshead Pharma Limited
Unaudited accounts
Contents
Gateshead Pharma Limited
Company Information
for the year ended 31 March 2025
Directors
A Akram
A Karim
Q Akram
Company Number
14658004 (England and Wales)
Registered Office
Leam Lane Pharmacy
Former Five Star Batteries
Meresyde
Gateshead
Tyne and Wear
NE10 8PE
England
Accountants
Ask Accountants NE Limited
The Grainger Suite, Dobson House
Regent Centre
Newcastle Upon Tyne
Tyne And Wear
NE3 3PF
Gateshead Pharma Limited
Statement of financial position
as at 31 March 2025
Intangible assets
1,032,018
231,744
Tangible assets
26,227
11,398
Cash at bank and in hand
143,559
100,488
Creditors: amounts falling due within one year
(765,596)
(489,426)
Net current liabilities
(79,040)
(192,986)
Total assets less current liabilities
979,205
50,156
Creditors: amounts falling due after more than one year
(824,770)
-
Provisions for liabilities
Deferred tax
(6,557)
(2,166)
Called up share capital
105
105
Profit and loss account
147,773
47,885
Shareholders' funds
147,878
47,990
For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 26 December 2025 and were signed on its behalf by
A Karim
Director
Company Registration No. 14658004
Gateshead Pharma Limited
Notes to the Accounts
for the year ended 31 March 2025
Gateshead Pharma Limited is a private company, limited by shares, registered in England and Wales, registration number 14658004. The registered office is Leam Lane Pharmacy, Former Five Star Batteries, Meresyde, Gateshead, Tyne and Wear, NE10 8PE, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
The accounts have been prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The accounts have been prepared under the historical cost convention.
In the prior period, the accounting reference date was changed to 31 March 2024, extending the reporting period by 48 days, to align the reference date to that of the company's parent's accounting reference date. Therefore, the comparatives are not entirely comparable.
Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of
sales/value added tax, returns, rebates and discounts.
The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Fixtures & fittings
10% reducing balance
Computer equipment
25% reducing balance
Intangible fixed assets (including purchased goodwill and patents) are included at cost less accumulated amortisation. Goodwill is considered to have a finite useful life and is amortised on a systemic basis over its expected life of 10 years.
Inventories have been valued at the lower of cost and estimated selling price less costs to complete and sell.
Gateshead Pharma Limited
Notes to the Accounts
for the year ended 31 March 2025
A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument.
Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments
discounted at a market rate of interest for a similar debt instrument.
Debt instruments are subsequently measured at amortised cost.
4
Intangible fixed assets
Goodwill
At 31 March 2025
1,132,799
Charge for the year
88,444
At 31 March 2025
1,032,018
5
Tangible fixed assets
Fixtures & fittings
Computer equipment
Total
Cost or valuation
At cost
At cost
At 1 April 2024
2,326
10,266
12,592
Additions
8,420
11,662
20,082
At 31 March 2025
10,746
21,928
32,674
At 1 April 2024
81
1,113
1,194
Charge for the year
615
4,638
5,253
At 31 March 2025
696
5,751
6,447
At 31 March 2025
10,050
16,177
26,227
At 31 March 2024
2,245
9,153
11,398
Gateshead Pharma Limited
Notes to the Accounts
for the year ended 31 March 2025
Amounts falling due within one year
Trade debtors
218,476
96,858
Other debtors
182,635
33,879
7
Creditors: amounts falling due within one year
2025
2024
Bank loans and overdrafts
38,629
-
Trade creditors
394,087
153,468
Taxes and social security
63,020
14,362
Other creditors
269,860
321,596
Included within creditors: amounts falling due within one year are bank loans which are secured by way of fixed and floating charges against the assets of the company.
8
Creditors: amounts falling due after more than one year
2025
2024
Included within creditors: amounts falling due after one year are bank loans which are secured by way of fixed and floating charges against the assets of the company.
Allotted, called up and fully paid:
100 Ordinary shares of £1 each
100
100
1 A ordinary shares of £1 each
1
1
1 B ordinary shares of £1 each
1
1
1 C ordinary shares of £1 each
1
1
1 D ordinary shares of £1 each
1
1
1 E ordinary shares of £1 each
1
1
The parent undertaking of the company is Ferndene Trading Ltd. The registered office of the parent undertaking is 4 Ingram Avenue, Newcastle upon Tyne, NE3 2BR, United Kingdom.
11
Average number of employees
During the year the average number of employees was 11 (2024: 6).